Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1683553 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $41.45Day −0.36%Mkt cap $114M1Y −93.8%Off 52W high −93.9%Vol (1Y) 1421.4%
Daily closing price, split-adjusted to the current basis; 2.9y shown of 1,353 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest15.1% of sh out |
| Days to cover6.1d |
| 13F net flow (QoQ)−2.65% |
| Top-10 13F concentration81.7% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$37.2M |
| ROE−109.2% |
| Debt / equity0.00× |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−52.4% |
| 1Y−93.8% |
| 3Y−99.7% |
| 5Y−99.9% |
| Since incept. (ann.)−76.8% |
Total return through 2026-07-29 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)1421.4% |
| Ann. volatility (3Y)814.0% |
| Sharpe (1Y)0.90 |
| Sharpe (3Y)0.46 |
| Max drawdown (1Y)−99.0% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)3.94 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Ikarian Capital, LLC | 121,356 | $8M | 4.41% | +0.0% |
| MILLENNIUM MANAGEMENT LLC | 111,888 | $7M | 4.07% | new |
| CITADEL ADVISORS LLC | 69,999 | $5M | 2.54% | +0.0% |
| ADAR1 Capital Management, LLC | 58,600 | $4M | 2.13% | +1.0% |
| Alyeska Investment Group, L.P. | 51,671 | $3M | 1.88% | +0.0% |
| WELLINGTON MANAGEMENT GROUP LLP | 48,796 | $3M | 1.77% | −17.2% |
| BOOTHBAY FUND MANAGEMENT, LLC | 42,080 | $3M | 1.53% | −12.2% |
| Balyasny Asset Management L.P. | 40,000 | $3M | 1.45% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$8.94 | — | — | — |
| 2025-12-31 | 2026-03-09 | — | — | $0 | −100.0% |
| 2025-09-30 | 2025-11-10 | −$14.58 | — | $0 | −100.0% |
| 2025-06-30 | 2025-08-14 | — | — | $0 | −100.0% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
